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1. Introduction
   Tuberculosis is considered to be one of the common 
problems in undeveloped and developing countries. 
isoniazid and rifampicin are integral parts of various 
dosage regimens available for treatment of tuberculosis. 
Drug induced hepatotoxicity is a main side effect of 
tuberculosis management regimens consisting of isoniazid 
and rifampicin[1]. As contrast to western countries, 
danger of hepatotoxicity is higher in India. On the basis 
of some Indian studies it can be considered to be around 
11.5%[2]. Mechanism responsible for hepatotoxicity due to 
antitubercular drug is not clearly understood till the date.
   Isoniazid is reported for its hepatotoxicity potential. 
Hepatic toxicity and hepatitis are supposed to be increased 
with concomitant use of many medication including 
rifampicin, and alcohol abuse. Elevated level of serum 
transaminase (aspartate transaminase and alanine 
transaminase), fatal hepatitis, bilirubinaemia, bilirubinuria, 
and jaundice, can occur with dosing schedule consisiting 
of isoniazid and rifampicin. The common prodromal 
symptoms of hepatitis are anorexia, nausea, vomiting, 
fatigue, malaise, and weakness[3]. Isoniazid and rifiampicin 
dosed simultaneously in rabbits caused an elevation in 
phospholipids and a reduction in phosphatidylcholine, 
cardiolipin and inorganic phosphates, possibly via a choline 
deficiency, which may lead to the observed liver toxicity. 
Isoniazid and rifampicin co-administration caused steatosis 
and increased apoptosis of the hepatocytes and hepatic 
oxidative stress[4,5]. 
   From above part it is clear that human beings can’t avoid 
taking drugs and some of these unavoidable drugs possess 
significant toxicity on liver. Leucas cephalotes (L. cephalotes) 
whole herb is used by tribal of India in treatment of various 
ailments. L. cephalotes is reported to possess potential 
in treatment of various diseases. It is reported to possess 







Objective: To investigate ameliorative effect of alcoholic extract of whole herb of Lucas cephalotes 
(L. cephalotes) on isoniazid and rifampicin induced hepatotoxicity.
Methods: Hepatoprotective potential of alcoholic extract of L. cephalotes was ascertained at 
200 mg/kg and 400 mg/kg in Sprague Dawley rats. Animals were intoxicated with isoniazid and 
rifampicin (100 mg/kg each, i.p.) for 21 d. Assessment was done on the basis of liver function 
test (serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, alkaline 
phosphatase and bilirubin); effect on enzymes involved in oxidative stress (lipid peroxidase, 
superoxide dismutase, glutathione and catalase) and histology of liver were assessed as well. 
Comparison among different treatment group was done using One way ANOVA followed by 
Benferroni’s t test. 
Results: It was observed that at both of the selected doses extract exhibited significant 
ameliorative effect. In animals treated with the extract at both doses, serum glutamic oxaloacetic 
transaminase, serum glutamic pyruvic transaminase, alkaline phosphatase, bilirubin and lipid 
peroxidase level was found to be significantly less (P<0.01) and superoxide dismutase, glutathione 
and catalase level was significantly high (P<0.01) as compared to intoxicated animals. 
Conclusions: From the present study it can be concluded that alcoholic extract of L. cephalotes 
possesses significant hepatoprotective potential against isoniazid and rifampicin induced 
heptoxicity.
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hepatoprotective= activity against carbon tetrachloride 
induced hepatotoxicity in wistar rats[6]. It is also reported 
to possess antiprotozoal, antioxidant, antidiabetic and 
antimicrobial activity[7-9]. On the basis of reported scientific 
and traditional evidence for hepatoprotective potential, 
the present study was designed to investigate protective 
potential of alcoholic extract of L. cephalotes whole plant 
against isonaizid and rifampicin induced hepatotoxicity.
2. Materials and methods
2.1. Experimental animals
   Sprague Dawley rats of either sex weighing (200依20) g 
were selected at random from animal house of Pinnacle 
Biomedical Research Institute, Bhopal. Animal were 
housed in propylene cage using sterile husk as bedding 
material. Animals were kept at (22依2) °C in 12:12 light-dark 
cycle. Animal housing conditions were maintained as per 
CPCSEA guidelines. Animals were sifted to experimental 
room one hour prior to commencement of experiment for 
acclimatization. All animal experiments were performed with 
prior permission from Institutional Animal Ethics Committee 
of Pinnacle Biomedical Research Institute, Bhopal (1283/c/09/
CPCSEA). 
2.2. Chemicals and instruments
   All biochemical investigations were performed using 
semi automatic biochemical analyzer (Star 21) and UV-vis 
spectrophotometer (Systronic, 2202) was used in estimation 
of enzymes involved in oxidative stress. All kits for liver 
function test were procured from Span Diagnostics, India. 
All other chemicals were of analytical grade, procured from 
Sigma Aldrich, USA, Himedia, and Merck, India.
2.3. Collection of plant material and extraction
   Whole plant of L. cephalotes was collected from 
Bhopal, Madhya Pradesh, India. Herbarium was prepared 
and submitted for authentication to Dr. Zia-ul Hasan, 
Department of Botany, Safia College of Science, Bhopal, 
Madhya Pradesh, India (Voucher specimen No. 162/Bot/
Safia/10). Plant material was dried under shade and crushed 
using electrical grinder. Pulverized plant material was 
packed in Soxhlet apparatus and extracted with methanol at 
40 °C, after defating with petroleum ether. Extract was dried 
under vacuum using rotary vacuum evaporator at 40 °C. 
Dried plant material was packed in air tight container at 4 °C 
for further use.
2.4. Acute oral toxicity 
   Extract was found to be freely soluble in distilled 
water, hence extract was dissolved in water for further 
investigations. Acute oral toxicity was performed as per 
Organization for Economic Co-operation and Development 
423 guidelines. Albino wistar rats were administered with 5 
mg/kg, 50 mg/kg, 300 mg/kg and 2 000 mg/kg of the extract. 
No mortality and no significant behavioural alteration 
were observed till 2 000 mg/kg, accordingly 2 000 mg/kg was 
considered to be no observed adverse effect level for present 
investigation. About 1/10 and 1/5 of 2 000 mg/kg, i.e. 200 mg/
kg and 400 mg/kg were selected as doses for further in vivo 
experiment.
2.5. Experimental design
   All animals were divided into five groups with six animals 
in each group. Distilled water was used as vehicle as 
extract was soluble in distilled water. Group I was vehicle 
treated group, administered with distilled water (1 mL/kg, 
p.o.). Group II was toxic control group, administered with 
isoniazid and rifampicin (100 mg/kg each, i.p.) dissolved 
in water for 21 d[10]. Vehicle was administered one hour 
prior to isoniazid and rifampicin administration. Group III 
and IV were test groups, administered with extract of L. 
cephalotes at 200 mg/kg, p.o. and 400 mg/kg, p.o. respectively 
with isoniazid and rifampicin (100 mg/kg each, i.p.) for 21 
d. Extract was administered one hour prior to isoniazid and 
rifampicin administration. Group V was standard drug group 
administered with Silymarin (200 mg/kg, p.o.) suspended in 
0.1% carboxymethyl cellulose. Vehicle, extract and Silymarin 
were administered one hour prior to isoniazid and rifampicin 
administration each day for 21 d. Twenty-four hours after 
last dosing, blood sample was collected through retro-
orbital puncture and animals were sacrificed by cervical 
dislocation under general anesthesia. Liver was collected 
for estimation of enzymes involved in oxidative stress and 
histopathological examination.
2.6. Biochemical investigation 
   Blood sample was centrifuged at 2 000 r/min and blood 
serum was used for biochemical studies. Serum glutamic 
oxaloacetic transaminase (SGOT), serum glutamic pyruvic 
transaminase (SGPT), alkaline phosphatase (ALP) and bilirubin 
level in different treatment groups was ascertained using 
biochemical analyser with the help of diagnostic kits.
2.7. Estimation of enzymes involved in oxidative stress
   Half of the liver was rinsed with ice cold normal saline 
followed by 0.15 mol/L Tris HCl (pH 7.4). For estimation 
of lipid peroxidase (LPO), 10% w/v tissue homogenate was 
prepared in 0.15 mol/L Tris HCl (pH 7.4); for glutathione 
(GSH), 10% w/v tissue homogenate was prepared in 0.1 mol/
L phosphate buffer (pH 7.4); for catalase 10% w/v tissue 
homogenate was prepared in 0.15 mol/L Tris HCl/0.1 mol/
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L phosphate buffer (pH 7.4), centrifuged at 15 000 r/min for 
15 min at 4 °C, supernatant was used as sample and for 
superoxide dismutase (SOD), tissue homogenate was prepared 
same as to that for catalase estimation[11]. 
2.7.1. Catalase estimation
   About 2.9 mL of H2O2 solution was taken and observed 
at 240 nm till absorbance became stable. About 2.9 mL of 
H2O2 solution and 0.1 mL test sample was added, mixed by 
inversion and the time required for the absorbance at 240 nm 
to decrease from 0.45 to 0.40 absorbance units was recorded. 
One unit was considered to decompose 1.0 µmol of H2O2 per 
minute at pH 7.0 at 25 °C, while the H2O2 concentration falls 
from 10.3 mmol/L to 9.2 mmol/L. The rate of disappearance 
of H2O2 is followed by observing the rate of decrease in the 
absorbance at 240 nm.
2.7.2. SOD estimation
   About 10% w/v tissue homogenate in 0.15 mol/L Tris HCl 
was prepared, centrifuged at 15 000 r/min for 15 min at 4 °C. 
Supernatant (0.1 mL) was taken and considered as sample. 
Briefly, 0.1 mL sample, 1.2 mL sodium pyrophosphate buffer 
(pH 8.3, 0.052 mol/L), 0.1 mL phenazine methosulphate (186 
µmol/L), 0.3 mL of 300 µmol/L nitrobluetetrazolium, and 1 
mL/kg reduced form of nicotinamide-adenine dinucleotid 
(750 µmol/L) was mixed and incubated at 30 °C for 90 seconds. 
About 0.1 mL glacial acetic acid was added, stirred with 4.0 
mL n-butanol, then allowed to stand for 10 min. Butanol 
layer was centrifuged and separated. Optical density (OD) 
at 560 nm was observed. One unit of SOD is the amount of 
enzyme that inhibit the rate of reaction by 50%.
2.7.3. LPO estimation
   About 10% w/v tissue homogenate in 0.15 mol/L Tris 
HCl buffer (pH 7.4) was prepared. Briefly, 1 mL/kg tissue 
homogenate, 1 mL/kg 8.1% sodium dodecyl sulfonate, 1.5 mL 
20% acetic acid and 1.5 mL 8% TBA were mixed and made 
up volume upto 4 mL with distilled water. The mixture was 
heated on waterbath (95 °C) for 60 min using glass ball as 
condenser, and then cooled and volume was made upto 5 
mL. A total of 5 mL of butanl: pyridine (15:1) was added and 
vortexed for 2 min, centrifuged at 3 000 r/min (10 min). The 
upper organic layer was taken and OD was observed at 532 
nm. 
2.7.4. GSH estimation
   Tissue homogenate (0.1 mol/L phosphate buffer 7.4 pH, 
10%) was prepared. About 1 mL/kg of homogenate was taken 
and 20% trichloroacetic acid and 1 mmol/L ethylene diamine 
tetraacetic acid were added. The mixture was set aside 
for 5 min and centrifuged for 10 min at 2 000 r/min. To the 
supernatant (200 µL), 1.8 mL of Ellman’s reagent [5,5’-dithio 
bis-2-nitrobenzoic acid (0.1 mmol/L) prepared in 0.3 mol/L 
phosphate buffer, pH 7 with 1% sodium citrate solution] was 
added. Volume was adjusted upto 2 mL with distilled water. 
OD was noted at 412 nm.
2.8. Histological examination
   Remaining part of liver was preserved in buffered formalin 
(10%) for histology. About 5 µm thick sections of liver were 
prepared using rotary microtome. Sections were stained with 
Hematoxylin and Eosin. Stained sections were observed 
under optical microscope at 40伊 magnification. 
2.9. Biostatical interpretation
   All data are presented in mean依SD (n=6). Data were 
analyzed by One-way ANOVA followed by Benferroni’s test. 
P<0.01 was considered as level of significance. 
3. Results
3.1. Acute oral toxicity
   Neither mortality nor any adverse effect was observed 
till 2 000 mg/kg. Hence for present study 2 000 mg/kg 
was selected as no observed adverse effect level for oral 
administration of methanolic extract of whole plant of L. 
cephalotes.
3.2. Hepatoprotective activity
   Animals of toxic control group had significantly elevated 
(P<0.01) level of SGOT, SGPT, ALP and bilirubin as compared 
to vehicle treated animals (Table 1). This confirmed the 
toxic effect of isoniazid and rifampicin at selected doses on 
liver. In animals of test group at both doses (i.e. 200 mg/kg 
and 400 mg/kg) there was significant protection observed for 
liver. This was confirmed on the basis of significantly lower 
Table 1
Effect of methanolic extract of L. cephalotes on liver function test in animals intoxicated with isoniazid and rifampicin.
Treatment group SGOT (IU/L) SGPT (IU/L) ALP (IU/L) Bilirubin (mg/dL)
Vehicle (1 mL/kg/d, p.o.) 58.21依4.66 45.23依2.84 102.00依5.02 0.280依0.031
Vehicle (1 mL/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.) 136.44依9.24a 86.63依6.42a  202.57依8.55a  0.860依0.052a
Extract (200 mg/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  76.64依5.83b 62.66依4.67b   132.21依8.75 b  0.450依0.021b
Extract (400 mg/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  69.32依4.76b 54.82依3.56b    121.05依10.67b  0.410依0.035b
Silymarin (200 mg/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  61.35依5.21b 49.67依3.98b   118.63依7.83b  0.350依0.022b
All data presented in mean依SD (n=6).
a P<0.01 as compared to vehicle treated group, b P<0.01 as compared to toxic control group. 
INH-RIF: isoniazid and rifampicin.
Bhini Bais and Payal Saiju /Asian Pac J Trop Biomed 2014; 4(Suppl 2): S633-S638S636
(P<0.01) level of SGOT, SGPT, ALP and bilirubin as compared 
to that of animals of toxic control group. Silymarin treated 
animals also had significantly lower (P<0.01) level of SGOT, 
SGPT, ALP and bilirubin as compared to animals of toxic 
control group. 
3.3. Effect on enzymes involved in oxidative stress
   In animals of toxic control group level of LPO was found 
to be significantly higher (P<0.01) as compared to vehicle 
treated animals. Level of SOD, GSH and catalase was found to 
be significantly lower (P<0.01) as compared to vehicle treated 
animals. This confirmed that administration of isoniazid 
and rifampicin caused significant oxidative stress in liver 
of animals of toxic control group. In extract treated animals 
at both doses, level of LPO was found to be significantly 
lower (P<0.01) as compared to toxic control group; level 
of SOD, GSH, and catalase was found to be significantly 
elevated (P<0.01) as compared to toxic control group. Effect 
of Silymarin was also found to be significantly protective 
against oxidative stress induced by the antitubercular drugs 
(Table 2).
3.4. Histological examination
   Histological examination of liver of vehicle treated animal 
revealed normal architecture (Figure 1). Central vein, 
portal triad, their respective vascular layer, sinusoids, and 
hepatocytes were found to be normal. 
Figure 1. Histology of liver of vehicle treated animal (40伊).
   In animals of toxic control group, fatty degeneration 
(steatosis), inflammation, degenerated hepatocytes, distended 
sinusoids, necrosis, and hypertrophy in hepatocytes were 
observed (Figure 2). 
Figure 2. Histology of liver of isoniazid and rifampicin with vehicle treated 
animal (40伊). Signs of inflammatory infiltration, steatosis, and vascular 
endothelial degeneration were observed.
   In extract treated animals at 200 mg/kg, mild signs of 
inflammation were present (Figure 3), but at 400 mg/kg liver 
of animals were found to retain normal architecture (Figure 
4). In Silymarin treated animals significant protection at 
histological level was also confirmed (Figure 5). 
Figure 3. Histology of liver animal treated with isoniazid, rifampicin and 
extract at 200 mg/kg (40伊). Significant protection with mild inflammation was 
observed.
Table 2
Effect of methanolic extract of L. cephalotes on enzymes involved in oxidative stress in animals intoxicated with isoniazid and rifampicin.
Treatment group LPO (nmol MDA/g tissue) SOD (IU/g tissue) GSH (µmol/g tissue) Catalase (IU/mg tissue)
Vehicle (1 mL/(kg·d), p.o.) 58.37依4.21 38.67依2.63 1.63依0.09 5.02依0.14
Vehicle (1 mL/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  86.78依5.64a  19.21依1.24a  0.42依0.02a  1.68依0.08a
Extract (200 mg/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  73.63依5.23b  29.67依2.05b  1.32依0.08b  3.85依0.15b
Extract (400 mg/(kg·d), p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  68.44依4.67b  31.24依1.56b 1.53依0.1b  4.06依0.38b
Silymarin (200 mg/(kg·d). p.o.)+INH-RIF (100 mg/(kg·d) each i.p.)  63.45依3.98b  35.06依2.04b  1.58依0.09b  4.88依0.25b
All data presented in mean依SD (n=6).
a P<0.01 as compared to vehicle treated group, b P<0.01 as compared to toxic control group.
MDA: methane dicarboxylic aldehyde, INH-RIF: isoniazid and rifampicin.
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Figure 4. Histology of liver of isoniazid and rifampicin with extract at 400 
mg/kg treated animal (40伊). Significant protection was observed.
Figure 5. Histology of liver of isoniazid and rifampicin with Silymarin at 200 
mg/kg treated animal (40伊). Significant protection was observed.
4. Discussion
   Since ancient time many medicinal plants heve been used 
in traditional system of medicine for treatment of various 
ailments. Many of these medicinal plants are reported 
to have significant protection against disease associated 
with liver. Drug induced hepatotoxicity is one of the 
major problem associated with use of many medication. 
Treatment of tuberculosis in general requires chronic 
administration with isoniazid and rifamicin. Amongst the 
various adverse effects of this combination, hepatotoxicity 
is the most noticeable one. Many investigators reported 
protective potential of medicinal plants against isoniazid 
and rifampicin induced hepatotoxicity. L. cephalotes is used 
traditionally in treatment of various diseases including liver 
disorders. Hence present study was designed to investigate 
protective potential of whole plant extract of L. cephalotes 
against isoniazid and rifampicin induced hepatotoxicity.
   Isoniazid is considered to be a highly effective drug in the 
prophylaxis and treatment of tuberculosis. Sub chronic or 
chronic, daily administration of isoniazid is considered to 
be involved in mild elevations of enzymes in liver activities 
up to 20% of patients and significant hepatotoxicity in 
approximately one to two percentage of patients receiving 
the drug. If this liver toxicity is not recognized in early stage, 
it can be fatal. It has been reported that isoniazid induced 
liver injury cannot be easily differentiated from viral hepatic 
disorder[4]. Anti-tuberculosis drugs cause liver cells to 
produce drug inflammatory reactions, and hypomethylation 
of the genome and LINE-1 repetitive elements caused by 
the inflammatory reactions can activate the genome and 
produce some products that are found in the tumor cells, 
thus probably progressing the inflammation toward cancer[5]. 
Rifampin is another primary component for the treatment and 
prophylaxis of tuberculosis. Previously, it has been reported 
that the incidence of hepatotoxicity is approximately 2.6% 
with isoniazid-rifampin co-administration but only 1.6% 
with isoniazid treatment alone and 1.1% with rifampin alone, 
suggesting the higher incidence of severe hepatotoxicity in 
patients co-treated with these two drugs.
   One possible mechanism for the additive or synergistic 
effects of rifampin on isoniazid hepatotoxicity may be 
through the induction of drug-metabolizing enzymes. 
Changes in lipids (both in serum and liver) are likely 
involved in the pathogenesis of isoniazid and rifampin 
induced hepatoxicity in rats[12]. The common prodromal 
symptoms of hepatitis are anorexia nausea, vomiting, fatigue, 
malaise, and weakness. Mild hepatic dysfunction, evidenced 
by mild and transient elevation of serum transaminase 
levels, occurs in 10%-20% of patients taking antitubercular 
drugs[3].
   Elevated serum transaminase (SGOT, SGPT), bilirubinaemia, 
bilirubinuria, jaundice, and occasionally severe and 
sometimes fatal hepatitis can occur with normal 
dosing regimens of antitubercular drugs. SGPT (Alanine 
Aminotransferase) is an enzyme found mainly in the 
liver that is released into the bloodstream when the 
liver is inflamed. An elevated alanine transaminase 
level is indicative of hepatocellular necrosis and has 
been used as a surrogate marker of liver injury. SGOT 
(asparate aminotransferase) is elevated when the aspartate 
transaminase, an enzyme found in the liver and some other 
body tissues is released into the bloodstream from the 
inflamed tissue. Low values are of no clinical interest and 
high values usually indicate hepatitis[13]. In present study 
it was observed that due to administration of isoniazid and 
rifampicin, significant elevation in SGOT and SGPT occurred. 
In extract treated animals at both doses these enzymes were 
found to be significantly less. 
   In liver, ALP is found histochemically in the microvilli of 
bile canaliculi and on the sinusoidal surface of hepatocytes. 
High values usually indicate that the bile is not flowing 
normally through the gall bladder and bile duct into the 
intestine, a condition called Astasis[13]. Bilirubin in body is 
a careful balance between production and removal of the 
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pigment in body. Hyperbilirubinemia seen in acute hepatitis 
is directly proportional to the degree of histological injury 
of hepatocytes and the longer course of the disease. In toxic 
control group, level of ALP and bilirubin was significantly 
higher as compared to vehicle treated animals. In extract 
treated animals at 200 mg/kg and 400 mg/kg, level of ALP and 
bilirubin was found to be significantly less as compared to 
toxic control group. This confirmed protective effect of L. 
cephalotes extract against isoniazid and rifampicin induced 
hepatotoxicity.
   Involvement of oxidative stress in hepatotoxicity caused 
by combination of isoniazid and rifampicin is already 
established. Sodhi et al. reported that at 50 mg/(kg·d) each 
of isoniazid and rifampicin for two weeks, SOD, glutathione 
peroxidase, catalase and glutathione-S-transferases 
decreases significantly[14]. Enhanced oxidative stress in 
antitubercular drug treated animals was confirmed on the 
basis of altered profile of antioxidant enzymes and increased 
lipid peroxidation[14]. 
   SOD is a class of closely related enzymes that catalyze 
the breakdown of the superoxide anion into oxygen and 
hydrogen peroxide. Catalases are enzymes that catalyze the 
conversion of hydrogen peroxide to water and oxygen, using 
either an iron or manganese cofactor. Biochemical function 
of glutathione peroxidase is to reduce lipid hydroperoxides 
to their corresponding alcohols and to reduce free hydrogen 
peroxide to water. Increasing one’s glutathione levels help 
the productivity of the glutathione peroxidase and vice 
versa. Lipid peroxidase is the enzyme involved in oxidative 
degradation of lipids. In the process free radicals steal 
electrons from the lipids in cell membranes, resulting in 
cell damage. This process proceeds by a free radical chain 
reaction mechanism. It most often affects polyunsaturated 
fatty acids, because they contain multiple double bonds 
in between which lie methylene groups that possess 
especially reactive hydrogen. In toxic control group level 
of SOD, GSH and catalase was significantly lower and LPO 
level was significantly higher. This confirmed the induction 
of oxidative stress due to administration of isoniazid and 
rifampicin in toxic control group. At both of the selected 
doses of extract, significant protection against oxidative 
stress was observed with increase in level of SOD, GSH and 
catalase and decrease in LPO level.
   L. cephalotes is reported for its hepatoprotective activity 
against carbon tetrachloride[6]. It is also reported for its 
antioxidant potential. Besides, the plant is also reported to 
contain triterpenes, oleanolic acid, sterols and flavones. 
Other constituents such as luteolin 4’-O-beta-D-
glucuronopyranoside, leucasdins A, B and C, lauric acid, 
tridecanoic acid, leucastrins A and B, adipic acid, glutaric 
acid and labellenic acid (seed oil) was also reported. Luteolin 
is considered to be hepatoprotective and antioxidant[15,16]. 
Thus from present investigation it can be concluded that 
methanolic extract of whole plant of L. cephalotes possesses 
significant hepatoprotective activity against isoniazid and 
rifampicin induced hepatotoxicity and this can be attributed 
to presence of flavones in extract.
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